These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 21237525)

  • 1. Analysis of urinary proteomic patterns for type 2 diabetic nephropathy by ProteinChip.
    Wu J; Chen YD; Yu JK; Shi XL; Gu W
    Diabetes Res Clin Pract; 2011 Feb; 91(2):213-9. PubMed ID: 21237525
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proteomic analysis for the assessment of diabetic renal damage in humans.
    Mischak H; Kaiser T; Walden M; Hillmann M; Wittke S; Herrmann A; Knueppel S; Haller H; Fliser D
    Clin Sci (Lond); 2004 Nov; 107(5):485-95. PubMed ID: 15281910
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of high dose thiamine on the levels of urinary protein biomarkers in diabetes mellitus type 2.
    Riaz S; Skinner V; Srai SK
    J Pharm Biomed Anal; 2011 Mar; 54(4):817-25. PubMed ID: 21130593
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of urinary soluble E-cadherin as a novel biomarker for diabetic nephropathy.
    Jiang H; Guan G; Zhang R; Liu G; Cheng J; Hou X; Cui Y
    Diabetes Metab Res Rev; 2009 Mar; 25(3):232-41. PubMed ID: 19177462
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proteomic identification of urinary biomarkers of diabetic nephropathy.
    Rao PV; Lu X; Standley M; Pattee P; Neelima G; Girisesh G; Dakshinamurthy KV; Roberts CT; Nagalla SR
    Diabetes Care; 2007 Mar; 30(3):629-37. PubMed ID: 17327332
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The significance of urinary enzymes in the early diagnosis of diabetic nephropathy].
    Delektorskaia LN; Okunev DIu; Shestakova MV
    Lab Delo; 1990; (7):10-4. PubMed ID: 1699056
    [No Abstract]   [Full Text] [Related]  

  • 7. [Qualitative study of proteinuria in diabetic nephropathy].
    Faure Nogueras E; Blasco Comenge MC; Guillén Martínez G
    An Med Interna; 1991 Jul; 8(7):333-5. PubMed ID: 1932490
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proteomic approaches for discovering biomarkers of diabetic nephropathy.
    Ben Ameur R; Molina L; Bolvin C; Kifagi C; Jarraya F; Ayadi H; Molina F; Granier C
    Nephrol Dial Transplant; 2010 Sep; 25(9):2866-75. PubMed ID: 20472580
    [No Abstract]   [Full Text] [Related]  

  • 9. Proteomic biomarkers in diabetic nephropathy--reality or future promise?
    Mischak H; Rossing P
    Nephrol Dial Transplant; 2010 Sep; 25(9):2843-5. PubMed ID: 20571095
    [No Abstract]   [Full Text] [Related]  

  • 10. Urinary N-acetyl-beta-glucosaminidase excretion in non-insulin-dependent diabetes mellitus: relation with diabetic nephropathy.
    Pérez-Blanco FJ; Sabatel-Hernández G; Cantero-Hinojosa J; Rodriguez-Cuartero A
    Clin Nephrol; 1998 Feb; 49(2):132-4. PubMed ID: 9524787
    [No Abstract]   [Full Text] [Related]  

  • 11. Elevation of urinary betaig-h3, transforming growth factor-beta-induced protein in patients with type 2 diabetes and nephropathy.
    Ha SW; Kim HJ; Bae JS; Jeong GH; Chung SC; Kim JG; Park SH; Kim YL; Kam S; Kim IS; Kim BW
    Diabetes Res Clin Pract; 2004 Aug; 65(2):167-73. PubMed ID: 15223229
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased urinary levels of CXCL5, CXCL8 and CXCL9 in patients with Type 2 diabetic nephropathy.
    Higurashi M; Ohya Y; Joh K; Muraguchi M; Nishimura M; Terawaki H; Yagui K; Hashimoto N; Saito Y; Yamada K
    J Diabetes Complications; 2009; 23(3):178-84. PubMed ID: 18413205
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of ruboxistaurin on urinary transforming growth factor-beta in patients with diabetic nephropathy and type 2 diabetes.
    Gilbert RE; Kim SA; Tuttle KR; Bakris GL; Toto RD; McGill JB; Haney DJ; Kelly DJ; Anderson PW
    Diabetes Care; 2007 Apr; 30(4):995-6. PubMed ID: 17229944
    [No Abstract]   [Full Text] [Related]  

  • 14. Utility of Albusure test in screening for early stage of diabetic nephropathy.
    Zhang J; Lnoue K; Nakashima N; Hiramatsu S; Ohashi M; Umeda F; Nawata H
    Chin Med J (Engl); 1994 Sep; 107(9):699-702. PubMed ID: 7805464
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma homocysteine is related to albumin excretion rate in patients with diabetes mellitus: a new link between diabetic nephropathy and cardiovascular disease?
    Chico A; Pérez A; Córdoba A; Arcelús R; Carreras G; de Leiva A; González-Sastre F; Blanco-Vaca F
    Diabetologia; 1998 Jun; 41(6):684-93. PubMed ID: 9662051
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Urinary type IV collagen excretion predicts subsequent declining renal function in type 2 diabetic patients with proteinuria.
    Katavetin P; Katavetin P; Susantitaphong P; Townamchai N; Tiranathanagul K; Tungsanga K; Eiam-Ong S
    Diabetes Res Clin Pract; 2010 Aug; 89(2):e33-5. PubMed ID: 20542586
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Study of urinary 8-hydroxydeoxyguanosine as a biomarker of oxidative DNA damage in diabetic nephropathy patients.
    Xu GW; Yao QH; Weng QF; Su BL; Zhang X; Xiong JH
    J Pharm Biomed Anal; 2004 Sep; 36(1):101-4. PubMed ID: 15351053
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reduction of macroalbuminuria with pentoxifylline in diabetic nephropathy. Report of three cases.
    Gorson DM
    Diabetes Care; 1998 Dec; 21(12):2190-1. PubMed ID: 9839116
    [No Abstract]   [Full Text] [Related]  

  • 19. Urinary type IV collagen levels in diabetes mellitus.
    Sthaneshwar P; Chan SP
    Malays J Pathol; 2010 Jun; 32(1):43-7. PubMed ID: 20614725
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exercise induced proteinuria as an early indicator of diabetic nephropathy.
    Agarwal RP; Thanvi I; Vachhani G; Kochar DK; Rastogi A
    J Assoc Physicians India; 1998 Sep; 46(9):772-4. PubMed ID: 11229244
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.